New insights into huperzine A for the treatment of Alzheimer's disease. - Test2 - elhamkhani - TriplyDB

New insights into huperzine A for the treatment of Alzheimer's disease.

New insights into huperzine A for the treatment of Alzheimer's disease.

http://www.wikidata.org/entity/Q37729474

about

Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress In Vitro Effects of Cognitives and Nootropics on Mitochondrial Respiration and Monoamine Oxidase Activity.Pharmacological Effects of Active Components of Chinese Herbal Medicine in the Treatment of Alzheimer's Disease: A Review.Celebrating the 80th anniversary of the Shanghai Institute of Materia Medica, Chinese Academy of Sciences (SIMM).Huperzine A inhibits CCL2 production in experimental autoimmune encephalomyelitis mice and in cultured astrocyte.Quantitative proteomic analysis reveals the neuroprotective effects of huperzine A for amyloid beta treated neuroblastoma N2a cells.New Lycopodium alkaloids from Lycopodium obscurum.Fraction n-Butanol of Radix Notoginseng Protects PC12 Cells from Aβ25-35-Induced Cytotoxicity and Alleviates Cognitive Deficits in SAMP8 Mice by Attenuating Oxidative Stress and Aβ Accumulation.Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.

P2860

Q36767908-C7153C4D-A06E-48C1-813F-545D31D6B3DB Q38818471-F754799E-C074-42B6-A4EE-6424B6E0C1B8 Q39009840-E06C6CD8-6606-4AEC-A509-389E498FE19E Q42543208-1B69DA81-E10A-4672-AA0E-31E688B3A8B7 Q44851919-8FC71409-9694-44C8-B878-FD558C1E8BBE Q45917550-E5CEF54A-AE93-4FA4-81F1-9CC15313A233 Q46096735-D3D322F8-36DB-45F6-9FA2-97E6B6AF2A27 Q46102764-622E23FA-B977-4F32-A301-CE679DABB54D Q49393483-1061F222-63EC-4F3B-A24E-9F1A453DE215

P2860

New insights into huperzine A for the treatment of Alzheimer's disease.

http://www.wikidata.org/entity/Q37729474

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 September 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

New insights into huperzine A for the treatment of Alzheimer's disease.

@en

New insights into huperzine A for the treatment of Alzheimer's disease.

@nl

type

label

New insights into huperzine A for the treatment of Alzheimer's disease.

@en

New insights into huperzine A for the treatment of Alzheimer's disease.

@nl

prefLabel

New insights into huperzine A for the treatment of Alzheimer's disease.

@en

New insights into huperzine A for the treatment of Alzheimer's disease.

@nl

P1433

Q37729474-D4115CAC-3DBE-48AC-A4B4-823DD9615A84

P1476

Q37729474-AAB87EB9-3F30-402B-A4CC-C87FF1BC6876

P2093

Q37729474-3F55F524-6AA8-4325-BF2E-8344C81D97E0

P2860

Q37729474-007E4A00-DD05-421B-BE55-5BEE29474DDA

Q37729474-028F4DAD-331A-4D3A-A826-4C12F60710ED

Q37729474-05D9FFDF-2BE5-4DFA-B2F4-7B08C9EAB83B

Q37729474-06827891-90CA-4729-9A96-99A0B52B4B64

Q37729474-12592054-4F31-4CDE-9F27-5D90EC206CCE

Q37729474-18C43E8A-F078-4A81-BA38-07D1D92C364F

Q37729474-1C6AF749-33B1-4A1E-9DC1-79270D801B99

Q37729474-22AEF53D-C8DE-44F3-8976-19402BE1B919

Q37729474-28AA600A-5C1C-4642-8FF3-692E352951CA

Q37729474-2DD18E98-7858-46EE-86B7-456C41808657

P2888

Q37729474-EB141473-C9D9-4345-848D-682C4CF3B4BF

P304

Q37729474-B9151C80-A856-46F6-8BB3-E8600212649E

P31

Q37729474-9b8e6dbe-6a9c-4a1d-8048-e02206b7fe2e

Q37729474-EA9FB379-BB35-4EA2-9A86-C30D28509466

P356

Q37729474-2ACCE3C9-BC68-4981-AE97-7D0A12FC40AA

P433

Q37729474-8A756FCD-AE3E-4CAA-BF01-992F72FC98EC

P478

Q37729474-E05353AC-BA8B-4F18-97B0-DBD9776BC539

P577

Q37729474-DA77BB9E-E5AA-41F8-A4F9-C45C9F290DDA

P5875

Q37729474-BB8A82AC-9A59-432D-9A9A-7B3AD38123B6

P698

Q37729474-26C36888-444E-4A0C-B421-6106D3C8BA2F

P921

Q37729474-310B6DCB-2F4C-482F-9F99-62AAC0619833

P932

Q37729474-98BDADC2-1A4D-41CC-9AD7-4BDE85F399D9

P356

P1433

Acta Pharmacologica Sinica

P1476

New insights into huperzine A for the treatment of Alzheimer's disease.

@en

P2093

Hai-Yan Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Alzheimer mechanisms and therapeutic strategies

Possible role of amyloid-beta, adenine nucleotide translocase and cyclophilin-D interaction in mitochondrial dysfunction of Alzheimer's disease

Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis

The cholinergic hypothesis of geriatric memory dysfunction

The internal structure of mitochondria.

Alpha7 nicotinic acetylcholine receptor: a link between inflammation and neurodegeneration.

A phase II trial of huperzine A in mild to moderate Alzheimer disease

Mitochondrial- and endoplasmic reticulum-associated oxidative stress in Alzheimer's disease: from pathogenesis to biomarkers.

Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine.

Low acetylcholine during slow-wave sleep is critical for declarative memory consolidation.

P2888

P304

1170-1175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/APS.2012.128

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230783525

http://www.w3.org/2001/XMLSchema#string

P698

22941287

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4003111

http://www.w3.org/2001/XMLSchema#string